Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, announced results from two retrospective, claims-based analyses providing health ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE